• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾功能障碍对心力衰竭的临床影响。

Clinical impact of renal dysfunction in heart failure.

机构信息

Department of Internal Medicine, Cardiology Section, Santa Maria alle Scotte Hospital, Siena, Italy.

出版信息

Rev Cardiovasc Med. 2011;12(4):186-99. doi: 10.3909/ricm0581.

DOI:10.3909/ricm0581
PMID:22249509
Abstract

Renal impairment in heart failure (HF) patients has been increasingly recognized as an independent risk factor for morbidity and mortality. In the most recent European and American guidelines for HF management, renal dysfunction was considered an index of poor prognosis independent of the presence of other traditionally investigated risk factors. Different mechanisms appear to be implicated in worsening renal function in patients with acute decompensated HF (ADHF) in contrast to chronic HF. In patients with acute ADHF, renal impairment has been attributed to renal hypoperfusion due to reduced cardiac output and decreased systemic blood pressure. In these patients, neurohormonal activation of the renin-angiotensin and sympathetic nervous systems plays a key role. In chronic and clinically stable HF, other mechanisms, including microvascular damage, oxidative stress, inflammation, and fibrosis, lead to a reduced number of functioning nephrons. Differentiating transient functional changes in renal filtration and acute renal tubular injury with loss of functioning nephrons is a critical step in understanding cardiorenal syndromes and selection of patients for novel therapeutic approaches.

摘要

心力衰竭(HF)患者的肾功能损害已日益被认为是发病率和死亡率的独立危险因素。在最近的欧洲和美国心力衰竭管理指南中,肾功能障碍被认为是预后不良的指标,独立于其他传统研究的危险因素。在急性失代偿性心力衰竭(ADHF)患者中,与慢性心力衰竭相比,不同的机制似乎与肾功能恶化有关。在急性 ADHF 患者中,由于心输出量降低和全身血压降低导致的肾脏低灌注导致了肾功能损害。在这些患者中,肾素-血管紧张素和交感神经系统的神经激素激活起着关键作用。在慢性和临床稳定的心力衰竭中,包括微血管损伤、氧化应激、炎症和纤维化在内的其他机制导致功能肾单位数量减少。区分肾功能滤过的短暂功能性变化和丧失功能肾单位的急性肾小管损伤是理解心肾综合征和选择新型治疗方法患者的关键步骤。

相似文献

1
Clinical impact of renal dysfunction in heart failure.肾功能障碍对心力衰竭的临床影响。
Rev Cardiovasc Med. 2011;12(4):186-99. doi: 10.3909/ricm0581.
2
Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).稳定型慢性心力衰竭中2型心肾综合征的病理生理学:急性透析质量倡议(ADQI)第十一次共识会议的工作组声明
Contrib Nephrol. 2013;182:117-36. doi: 10.1159/000349968. Epub 2013 May 13.
3
Cardiorenal syndrome in acute decompensated heart failure.急性失代偿性心力衰竭中的心肾综合征
Expert Rev Cardiovasc Ther. 2012 Feb;10(2):177-89. doi: 10.1586/erc.11.193.
4
Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure.1 型心肾综合征:急性失代偿性心力衰竭时导致心脏和肾脏功能障碍合并的病理生理学相互作用。
J Am Coll Cardiol. 2012 Sep 18;60(12):1031-42. doi: 10.1016/j.jacc.2012.01.077. Epub 2012 Jul 25.
5
Current therapeutic strategies in cardiorenal syndrome.心肾综合征的当前治疗策略。
Minerva Cardioangiol. 2012 Aug;60(4):375-83.
6
Cardio-renal syndrome type 1: epidemiology, pathophysiology, and treatment.心肾综合征 1 型:流行病学、病理生理学和治疗。
Semin Nephrol. 2012 Jan;32(1):18-25. doi: 10.1016/j.semnephrol.2011.11.003.
7
The cardiorenal syndrome: a mutual approach to concomitant cardiac and renal failure.心肾综合征:一种应对心脏和肾脏同时衰竭的综合方法。
Isr Med Assoc J. 2012 Sep;14(9):570-6.
8
Cardiorenal interactions in acute decompensated heart failure: contemporary concepts facing emerging controversies.急性失代偿性心力衰竭中的心肾相互作用:面对新出现争议的当代概念
J Card Fail. 2014 Dec;20(12):1004-11. doi: 10.1016/j.cardfail.2014.09.005. Epub 2014 Sep 16.
9
Renal function as a predictor of prognosis in chronic heart failure.肾功能作为慢性心力衰竭预后的预测指标
Heart Fail Monit. 2002;2(3):78-84.
10
Cardio-renal syndrome: an entity cardiologists and nephrologists should be dealing with collegially.心肾综合征:心内科医生和肾科医生应协同处理的病症。
Heart Fail Rev. 2011 Nov;16(6):503-8. doi: 10.1007/s10741-011-9267-x.

引用本文的文献

1
Model for End-Stage Liver Disease Excluding INR Is Associated with Poor Prognosis in Elderly Patients with Decompensated Heart Failure.排除国际标准化比值的终末期肝病模型与老年失代偿性心力衰竭患者的不良预后相关。
Biomedicines. 2025 Aug 18;13(8):2000. doi: 10.3390/biomedicines13082000.
2
Clinical Impact of Renal Dysfunction in Patients with Severe Tricuspid Regurgitation and Chronic Heart Failure.严重三尖瓣反流和慢性心力衰竭患者肾功能不全的临床影响
Rev Cardiovasc Med. 2025 Mar 5;26(3):26080. doi: 10.31083/RCM26080. eCollection 2025 Mar.
3
The role of fibrosis, inflammation, and congestion biomarkers for outcome prediction in candidates to cardiac resynchronization therapy: is "response" the right answer?
纤维化、炎症和充血生物标志物在心脏再同步治疗候选者结局预测中的作用:“反应”是正确答案吗?
Front Cardiovasc Med. 2023 Jun 12;10:1180960. doi: 10.3389/fcvm.2023.1180960. eCollection 2023.
4
The Treatment of Heart Failure in Patients with Chronic Kidney Disease: Doubts and New Developments from the Last ESC Guidelines.慢性肾脏病患者心力衰竭的治疗:对最新欧洲心脏病学会指南的疑问与新进展
J Clin Med. 2022 Apr 17;11(8):2243. doi: 10.3390/jcm11082243.
5
Cardiac MRI assessment of the right ventricle pre-and post-kidney transplant.心脏 MRI 评估肾移植前后的右心室。
Int J Cardiovasc Imaging. 2021 May;37(5):1757-1766. doi: 10.1007/s10554-020-02153-4. Epub 2021 Jan 21.
6
Clinical relevance of biomarkers in heart failure and cardiorenal syndrome: the role of natriuretic peptides and troponin.心力衰竭和心肾综合征中生物标志物的临床相关性:利钠肽和肌钙蛋白的作用。
Heart Fail Rev. 2014 Mar;19(2):267-84. doi: 10.1007/s10741-013-9391-x.